CONSHOHOCKEN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering n...
Xeris Biopharma Competitors or Alternatives
Xeris Biopharma's top competitors include Zealand, GlucaGen Hypokit and Fresenius Kabi.
Xeris Biopharma VS Zealand
Zealand is Xeris Biopharma's #1 competitor. Zealand is a Public company that was founded in 1998 in Soborg, Capital Region. Zealand is in the Biotechnology industry. Compared to Xeris Biopharma, Zealand has 27 fewer employees.
Xeris Biopharma VS GlucaGen Hypokit
GlucaGen Hypokit is seen as one of Xeris Biopharma's biggest rivals. GlucaGen Hypokit was founded in , } in undefined. GlucaGen Hypokit is in the Pharmaceuticals field. Compared to Xeris Biopharma, GlucaGen Hypokit generates $ less revenue.
Xeris Biopharma VS Fresenius Kabi
Fresenius Kabi is one of Xeris Biopharma's top competitors. Fresenius Kabi is headquartered in Bad Homburg, Baden-Württemberg, and was founded in 1999. Fresenius Kabi competes in the Health Care Equipment industry. Fresenius Kabi generates 4,219% the revenue of Xeris Biopharma.
Looking for similar companies to Xeris Biopharma?
Similar Companies
Pharmaceuticals companies in Chicago
See 78 companies
Pharmaceuticals companies in Chicago Metropolitan AreaSee 201 companies
Pharmaceuticals & Biotechnology companies in ChicagoSee 149 companies
Biotechnology companies in Chicago Metropolitan AreaSee 195 companies
Biotechnology companies in ChicagoSee 92 companies
Biotechnology companies in IllinoisSee 231 companies
Biotechnology companies with revenue in $100-500M rangeSee 233 companies
Pharmaceuticals companies in IllinoisSee 239 companies
Companies in Chicago with revenue in $100-500M rangeSee 250 companies
Trending News for Xeris Biopharma and Xeris Biopharma's Competitors
NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced the FDA has approved IMAAVY, a human FcRn-blocking monoclonal antibody, for the treatment o...
Illness in the family sparked Christopher Hibbler's interest in medicine. Our MAPS program is helping make his dream come true NORTHAMPTON, MA / ACCESS...
Early findings from Johnson & Johnson's Phase IIb SunRISe-1 trial show the promise of TAR-200 in patients with Bacillus Calmette-Guérin-unresponsive, h...
(RTTNews) - Johnson & Johnson (JNJ) announced the FDA has approved IMAAVY, a human FcRn-blocking monoclonal antibody, for the treatment of generalized ...
The company has predicted that Imaavy - now approved for generalized myasthenia gravis - could eventually earn more than $5 billion in annual sales at ...
April 25, 2025 - Medtronic plc, a global leader in healthcare technology, recently received U.S. Food and Drug Administration (FDA) approval for the Om...
With a market cap of $107.8 billion , Medtronic plc ( MDT ) develops, manufactures, and sells device-based medical therapies to healthcare systems, phy...
HTF MI just released the Global Medical Warming Devices Market Study, a comprehensive analysis of the market that spans more than 143+ pages and descri...
The latest report (2025-2032) on the Cardiac Pacing Leads Market by Coherent Market Insights delivers a deep dive into key market trends, drivers, chal...
Frequently Asked Questions about Xeris Biopharma
Who are Xeris Biopharma's top competitors?
Xeris Biopharma's top 3 competitors are Zealand, GlucaGen Hypokit, Fresenius Kabi.Who is similar to Xeris Biopharma?
Zealand is the most similar to Xeris Biopharma. GlucaGen Hypokit and Fresenius Kabi are also similar to Xeris Biopharma.
Are Xeris Biopharma and Zealand competitors?
Yes, Zealand is one of Xeris Biopharma’s top competitors.